LIVE - Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

Filed today

Companies tracked

NSE & BSE

Listed on

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.

Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split

Data sourced from BSE India corporate announcements. More categories will be added over time.

J.G.Chemicals Ltd

J.G.Chemicals Ltd: FY26 Audited Results & 11% Dividend Recommendation

RESULTS ▲ Positive Development LOW RISK

📅 Filed on BSE: 14 May 2026, 08:10 PM IST · BSE ID: d16f4ed4-0e05-442d-8186-a80851f4976a

View Original BSE Filing (PDF)

💡

In Simple Terms

The company reported its full-year financial results, proposed a dividend, and delayed spending Rs. 42.62 million from its IPO on an R&D centre.

🤖 AI Summary

J.G.Chemicals Ltd Board approved Audited Financial Results (Standalone & Consolidated) for Q4 FY26 and full FY26.
Board recommended a Final Dividend of 11% or ₹1.10 per Equity Share of ₹10 each for FY26.
Rs. 42.62 million of IPO proceeds for R&D Centre unutilized as of March 31, 2026.
Deployment of unutilized IPO funds for R&D Centre extended to Fiscal Year 2027 due to project delays.
Re-appointed M/s Debabrota Banerjee & Associates as Cost Auditor and SS Kothari Mehta & Co. LLP as Internal Auditor for FY27.

🔢 Key Numbers - exact figures from BSE filing, not rounded

Final Dividend per Equity Share

₹1.10

Final Dividend Percentage

11%

Unutilized IPO Proceeds for R&D Centre

Rs. 42.62 million

IPO Proceeds Utilized (as per Monitoring Agency)

Rs. 131.466 Crores

🏢 How This Affects the Company

📈

Business Impact

The extension of the timeline for utilizing Rs. 42.62 million for the R&D Centre indicates a delay in expanding future innovation capabilities.

💰

Financial Impact

The recommendation of an 11% final dividend indicates management's intent to distribute profits to shareholders from the FY26 earnings.

⚙️

Operational Impact

The re-appointment of internal, cost, and tax auditors ensures continuity in financial oversight and compliance for the upcoming fiscal year.

⚠️

Risk Impact

The delay in deploying Rs. 42.62 million of IPO proceeds for the R&D Centre due to construction and procurement issues introduces a timing risk for its planned utilization.

👥 What This Means For Shareholders

✅

Action Required

Shareholders must approve the recommended 11% final dividend at the upcoming 25th Annual General Meeting to receive payment.

👤

Who Is Affected

All shareholders holding equity shares of ₹10 each will be affected by the 11% (₹1.10 per share) dividend recommendation, pending approval.

🔍

Management Signal

Management signals commitment to shareholder returns through dividend recommendation while acknowledging delays in IPO fund utilization for R&D expansion.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events

Shareholder approval of the 11% dividend at the 25th Annual General Meeting.

Intimation of book closure/record date for the dividend payment.

Future updates on the utilization of Rs. 42.62 million IPO funds for the R&D Centre in FY27.

LOW RISK The primary concern is the delay in IPO fund utilization, which is explicitly addressed with a revised timeline.

💡 Investor Takeaway

J.G.Chemicals Ltd's Board approved FY26 audited financial results and recommended an 11% (₹1.10 per share) final dividend. Rs. 42.62 million of IPO proceeds for the R&D Centre remain unutilized as of March 31, 2026, with deployment extended to FY27 due to project delays.

⚖️ Strengths & Concerns

✅ Positives

Board recommended a final dividend of 11% @ ₹1.10 per Equity Share of ₹10 each for FY26, pending shareholder approval.
Audited Financial Results (Standalone and Consolidated) for FY26 were approved with unmodified audit opinions.

⚠️ Concerns

Rs. 42.62 million of IPO proceeds remain unutilized as of March 31, 2026, for the R&D Centre, extended to FY27.
Delay in utilizing IPO proceeds is attributed to construction works and equipment procurement delays, impacting project timelines.

📅 Company Track Record

J.G.Chemicals Ltd recently listed via an IPO in March 2024. The Board previously approved FY26 results and recommended an 11% dividend on May 14, 2026. This filing is a continuation of the intimation on May 9, 2026, regarding the Board meeting to approve FY26 results and consider a dividend.

Based on publicly available historical data. For context only.

📑 More from J.G.Chemicals Ltd

J.G. Chemicals Appoints Sunil Duggal & Kaushik Roy as Independent Directors

MANAGEMENT · 03 Nov 2026

J.G.Chemicals: Q2 FY27 Results Approved, Two Independent Directors Appointed

RESULTS · 03 Nov 2026

J.G.Chemicals Board Approves Q2 FY27 Results, Appoints Two Independent Directors

RESULTS · 03 Nov 2026

J.G. Chemicals to consider Q2 FY27 Unaudited Results on Nov 3

BOARD · 28 Oct 2026

J.G.Chemicals Ltd: Independent Director Ashok Bhandari Passes Away

MANAGEMENT · 03 Aug 2026

J.G.Chemicals Board Meeting Scheduled to Approve Q1 FY27 Results

RESULTS · 01 Aug 2026

All BSE filings we have analysed for J.G.Chemicals Ltd.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

Follow companies and get filings by email
Save any filing to read later
Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.